Nantes, France

Dimitri Alvarez-Dorta

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.6

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Profile: Dimitri Alvarez-Dorta

Introduction

Dimitri Alvarez-Dorta is a notable inventor based in Nantes, France. His work primarily focuses on developing innovative solutions for treating various inflammatory and metabolic diseases. With a total of three patents to his name, Dimitri is making significant contributions to the field of pharmaceutical sciences.

Latest Patents

Dimitri's latest patents revolve around orally available compounds designed as anti-adhesive drugs. These compounds are specifically aimed at treating induced inflammatory bowel diseases, including Crohn's disease. One of his key innovations includes mannose derivatives that are useful for treating pathologies associated with adherent entities, particularly in inflammatory bowel diseases. Notably, these derivatives also find applications in treating urinary tract infections, irritable bowel syndrome, metabolic diseases, autoimmune inflammatory diseases, and even colorectal cancer.

Career Highlights

Dimitri has been associated with prestigious research institutions, including the Centre National de la Recherche Scientifique and the University of Nantes. His time at these institutions has undoubtedly enriched his expertise and contributed to his innovative research pursuits.

Collaborations

Throughout his career, Dimitri has collaborated with talented individuals such as Julie Bouckaert and Sebastien Gouin. These collaborations have been instrumental in the development of his patented inventions, fostering a creative environment that promotes scientific advancement.

Conclusion

Dimitri Alvarez-Dorta stands out as a forward-thinking inventor whose work is paving the way for future innovations in medical treatments. His dedication to addressing complex health issues through his patented inventions reflects a profound commitment to improving patient outcomes and advancing scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…